Shisong Han

2.3k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Shisong Han is a scholar working on Biomedical Engineering, Immunology and Molecular Biology. According to data from OpenAlex, Shisong Han has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Biomedical Engineering, 14 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Shisong Han's work include Nanoplatforms for cancer theranostics (24 papers), Nanoparticle-Based Drug Delivery (9 papers) and Immune cells in cancer (7 papers). Shisong Han is often cited by papers focused on Nanoplatforms for cancer theranostics (24 papers), Nanoparticle-Based Drug Delivery (9 papers) and Immune cells in cancer (7 papers). Shisong Han collaborates with scholars based in China, Hong Kong and United States. Shisong Han's co-authors include Xintao Shuai, Jinsheng Huang, Yong Wang, Zecong Xiao, Bin Yang, Hong Xiao, Yu Guo, Xinying Yu, Bo Li and Yongcheng An and has published in prestigious journals such as Nano Letters, ACS Nano and Biomaterials.

In The Last Decade

Shisong Han

38 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy

2021 182 citations Jinsheng Huang, Zecong Xiao et al. Biomaterials profile →

Peers

Shisong Han

BIOMA

IMMUN

Jinsheng Huang China

Yingqiu Qi China

Xianbin Ma China

Guangna Liu China

Junchao Xu China

Anvay Ukidve United States

Qingpo Li China

Hao Qin China

Haihua Xiao China

Xiuwen Guan China

Jinsheng Huang China

Shisong Han

848 ×0.7

754 ×1.1

406 ×0.7

BIOMA

395 ×0.9

IMMUN

269 ×0.9

Citations per year, relative to Shisong Han Shisong Han (= 1×) peers Jinsheng Huang

Countries citing papers authored by Shisong Han

Since Specialization

Citations

This map shows the geographic impact of Shisong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shisong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shisong Han more than expected).

Fields of papers citing papers by Shisong Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shisong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shisong Han. The network helps show where Shisong Han may publish in the future.

Co-authorship network of co-authors of Shisong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Shisong Han. A scholar is included among the top collaborators of Shisong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shisong Han. Shisong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ding, Qi, et al.. (2025). Resistance of first-line targeted drugs in hepatocellular carcinoma: the epigenetic regulation mechanisms. Cell Death and Disease. 16(1). 875–875.

Zhang, Mingshuang, et al.. (2025). A fully biodegradable and self-regulating injectable silk fibroin hydrogel for glucose-responsive insulin delivery. Applied Materials Today. 44. 102700–102700. 2 indexed citations

Jiang, Yong, Yu Chen, Yuwei Li, et al.. (2024). Amplifying STING activation and immunogenic cell death by metal-polyphenol coordinated nanomedicines for enhanced cancer immunotherapy. Chinese Chemical Letters. 36(5). 110437–110437. 8 indexed citations

Deng, Jian, et al.. (2024). A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein. Chinese Chemical Letters. 35(11). 109584–109584. 5 indexed citations

Zhang, Ziying, et al.. (2024). A nanodrug loading indocyanine green and metformin dually alleviating tumor hypoxia for enhanced chemodynamic/sonodynamic therapy. Journal of Colloid and Interface Science. 680(Pt B). 341–355. 9 indexed citations

Zhang, Mingshuang, et al.. (2024). Biodegradable silk fibroin membranes for potential localized treatment of melanoma: optimized preparation and in vitro study. Biomedical Materials. 20(1). 15025–15025. 3 indexed citations

Xiao, Hong, Xiaoxia Li, Bo Li, et al.. (2023). Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma. Acta Biomaterialia. 161. 265–274. 31 indexed citations

Huang, Jinsheng, Huiling Huang, Yiyao Wang, et al.. (2023). Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation. Biomaterials. 299. 122134–122134. 29 indexed citations

Yu, Xinying, Yuwei Li, Chaoqun Wang, et al.. (2023). Supermolecular nanovehicles co-delivering TLR7/8-agonist and anti-CD47 siRNA for enhanced tumor immunotherapy. International Journal of Biological Macromolecules. 251. 126539–126539. 12 indexed citations

10.

Huang, Yufeng, Jiaming Lin, Anfei Huang, et al.. (2023). A nanodrug combining CD47 and sonodynamic therapy efficiently inhibits osteosarcoma deterioration. Journal of Controlled Release. 355. 68–84. 49 indexed citations

11.

Qiao, Lihong, et al.. (2023). A chemodynamic nanoenzyme with highly efficient Fenton reaction for cancer therapy. Biomedical Materials. 18(5). 55024–55024. 8 indexed citations

12.

Huang, Jinsheng, Zecong Xiao, Yongcheng An, et al.. (2021). Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy. Biomaterials. 269. 120636–120636. 182 indexed citations breakdown →

13.

Su, Zhenwei, Zecong Xiao, Jinsheng Huang, et al.. (2021). Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy. ACS Applied Materials & Interfaces. 13(11). 12845–12856. 47 indexed citations

14.

Liu, Mingyu, Guo Zhou, Ye Chen, et al.. (2021). Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosis. Free Radical Biology and Medicine. 175. 193–205. 12 indexed citations

15.

Jing, Yihan, Boguang Yang, Weihao Yuan, et al.. (2020). Dynamic cell-adaptable hydrogels with a moderate level of elasticity promote 3D development of encapsulated cells. Applied Materials Today. 22. 100892–100892. 19 indexed citations

16.

Yu, Xinying, et al.. (2020). Nanomedicine-based tumor photothermal therapy synergized immunotherapy. Biomaterials Science. 8(19). 5241–5259. 150 indexed citations

17.

Xiao, Hong, Yu Guo, Bo Li, et al.. (2020). M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects. ACS Central Science. 6(7). 1208–1222. 176 indexed citations

18.

Yu, Meng, Xiaohui Duan, Yujun Cai, et al.. (2019). Multifunctional Nanoregulator Reshapes Immune Microenvironment and Enhances Immune Memory for Tumor Immunotherapy. Advanced Science. 6(16). 1900037–1900037. 116 indexed citations

19.

Zeng, Zhengyang, Shisong Han, Wei Hong, et al.. (2016). A Tat-conjugated Peptide Nucleic Acid Tat-PNA-DR Inhibits Hepatitis B Virus Replication In Vitro and In Vivo by Targeting LTR Direct Repeats of HBV RNA. Molecular Therapy — Nucleic Acids. 5. e295–e295. 37 indexed citations

20.

Hong, Wei, Tian Li, Yu Song, et al.. (2013). Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1. Antiviral Research. 102. 1–10. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact